Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TELA Bio (TELA) Research & Development (2018 - 2025)

TELA Bio (TELA) has 8 years of Research & Development data on record, last reported at $2.3 million in Q3 2025.

  • For Q3 2025, Research & Development rose 13.54% year-over-year to $2.3 million; the TTM value through Sep 2025 reached $9.1 million, down 3.69%, while the annual FY2024 figure was $8.8 million, 8.38% down from the prior year.
  • Research & Development reached $2.3 million in Q3 2025 per TELA's latest filing, up from $2.2 million in the prior quarter.
  • Across five years, Research & Development topped out at $2.7 million in Q4 2022 and bottomed at $1.4 million in Q3 2021.
  • Average Research & Development over 5 years is $2.2 million, with a median of $2.1 million recorded in 2022.
  • Peak YoY movement for Research & Development: skyrocketed 97.14% in 2021, then decreased 24.43% in 2024.
  • A 5-year view of Research & Development shows it stood at $1.7 million in 2021, then skyrocketed by 58.03% to $2.7 million in 2022, then decreased by 1.5% to $2.7 million in 2023, then decreased by 24.43% to $2.0 million in 2024, then rose by 15.72% to $2.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Research & Development were $2.3 million in Q3 2025, $2.2 million in Q2 2025, and $2.5 million in Q1 2025.